Christie Foundation Trust

Manchester M20 4BX

0 studies enrolling now · 2 studies all time

What they study most

Non-small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer

Studies at this site

• A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer — Completed